News and Trends 7 May 2020 BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies US biotech BioMarin has partnered Swiss startup DiNAQOR to develop gene therapies to treat rare, inherited cardiac diseases. DiNAQOR will initially receive an upfront payment from BioMarin, followed by developmental, regulatory, and commercial milestone payments and a percentage of royalties on later sales. No financial details of the collaboration were revealed by either company. “We […] May 7, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 27 Feb 2020 Scientists Connect Brain Cells to Machines Over the Internet An international group of researchers has set up a brain-machine interface between cultured nerve cells and electronic chips linked over the internet, which could lead to the development of AI implants for treating neurological disorders. As described in a study published in Nature Scientific Reports, the team set up a system where cultured rat nerve […] February 27, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 14 Feb 2020 Novadiscovery Carries out Clinical Trials using AI and Simulations Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes and cut their running costs. Mission: To predict the outcomes of clinical trials in silico using a combination of artificial intelligence (AI) and computational models of the biology underlying the disease. Clinical trials cost the healthcare industry billions of euros […] February 14, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2020 Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI for the treatment of autism spectrum disorder in phase I. The round consists of a recent €7M (CHF 7.7M) closing and an initial first tranche of €9.3M (CHF 10M) raised last year. The investors in the latest closing were not […] February 4, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jan 2020 A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’ A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient […] January 28, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Dec 2019 €14M Series A to Fund Cancer Immunotherapy Boosting Checkpoint Inhibitors The Swiss biotech ImmunOs Therapeutics has raised a Series A round of €13.7M (CHF 15M) that will fund the first human trials of its cancer immunotherapy that could improve the response of cancer patients to checkpoint inhibitors. The round was co-led by the Swiss life sciences venture capital firm BioMedPartners and by Pfizer Ventures. The […] December 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2019 ObsEva’s Oral Treatment for Uterine Fibroids Nails Phase III An oral drug developed by the Swiss company ObsEva was shown to reduce menstrual bleeding and pain caused by uterine fibroids. The phase III trial tested ObsEva’s drug candidate linzagolix in 535 women suffering from heavy menstrual bleeding caused by benign tumors in the uterus called uterine fibroids. The effects of the drug were compared […] December 10, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 9 Dec 2019 Scientists Use DNA Data Storage to Hide Information in Everyday Objects Scientists have developed a method for storing DNA data in 3D-printed objects, which could one day allow machines to replicate themselves. The group, based at ETH Zurich, Switzerland, as well as in Israel and the US, began by synthesizing DNA molecules that encode blueprints of the Stanford bunny, a rabbit-shaped object commonly used in testing […] December 9, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 26 Nov 2019 Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor Fresenius Medical Care Renal Pharma (VFMCRP) was more effective at treating a rare inflammatory vascular disease than current treatments in a phase III trial. The drug avacopan was trialed in 331 patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. This life-threatening condition […] November 26, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 18 Sep 2019 €15M to Take Swiss Biotech’s Liver Cirrhosis Treatment to Phase II Versantis has raised a Series B of €14.6M (CHF 16M) to advance its treatment for late-stage liver cirrhosis to a phase IIa trial. The money will finance the completion of an ongoing phase I trial of Versantis’ lead candidate for the condition decompensated liver cirrhosis. Following this, the company will use the funds to launch […] September 18, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2019 Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict within just five minutes which intensive care patients are likely to develop sepsis in a clinical study. In the pivotal study, Abionic trialed the blood test in 300 intensive care patients with a high risk of sepsis. Abionic found that […] September 16, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Sep 2019 IBM’s Watson for Genomics Launches in First European Hospital The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […] September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email